MorphoSys (MOR)
(Delayed Data from NSDQ)
$18.04 USD
-0.09 (-0.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.05 +0.01 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for MorphoSys AG Unsponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 258 | 293 | 213 | 374 | 80 |
Cost Of Goods | 63 | 51 | 38 | 10 | 14 |
Gross Profit | 195 | 242 | 174 | 364 | 67 |
Selling & Adminstrative & Depr. & Amort Expenses | 468 | 474 | 503 | 343 | 188 |
Income After Depreciation & Amortization | -273 | -233 | -328 | 21 | -121 |
Non-Operating Income | 220 | 426 | -157 | 115 | 4 |
Interest Expense | 154 | 175 | 215 | 110 | 3 |
Pretax Income | -207 | 18 | -699 | 26 | -119 |
Income Taxes | -1 | 178 | -91 | -86 | -4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -205 | -159 | -609 | 112 | -115 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -205 | -159 | -609 | 112 | -115 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -262 | -221 | -317 | 30 | -114 |
Depreciation & Amortization (Cash Flow) | 11 | 11 | 12 | 10 | 7 |
Income After Depreciation & Amortization | -273 | -233 | -328 | 21 | -121 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 137.22 | 136.74 | 133.64 | 132.67 | 126.38 |
Diluted EPS Before Non-Recurring Items | -1.50 | -1.16 | -4.56 | 0.85 | -0.91 |
Diluted Net EPS (GAAP) | -1.50 | -1.16 | -4.55 | 0.85 | -0.91 |
Fiscal Year end for MorphoSys AG Unsponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 63.61 | 69.41 | 57.97 | 66.89 |
Cost Of Goods | NA | 15.82 | 16.41 | 8.40 | 22.53 |
Gross Profit | NA | 47.79 | 53.00 | 49.57 | 44.37 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 135.79 | 108.54 | 104.69 | 118.97 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -88.00 | -55.54 | -55.12 | -74.60 |
Non-Operating Income | NA | 183.25 | -25.55 | 5.34 | 57.25 |
Interest Expense | NA | 43.86 | 48.58 | 30.88 | 30.34 |
Pretax Income | NA | 51.39 | -129.68 | -80.65 | -47.69 |
Income Taxes | NA | -1.78 | 0.50 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 53.17 | -130.17 | -80.65 | -47.69 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 53.17 | -130.17 | -80.65 | -47.69 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 158.36 | 136.69 | 137.04 | 136.62 |
Diluted EPS Before Non-Recurring Items | NA | 0.33 | -0.95 | -0.59 | -0.35 |
Diluted Net EPS (GAAP) | NA | 0.39 | -0.95 | -0.59 | -0.35 |